Ghent, Belgium -- The Flanders Interuniversity Institute for Biotechnology (VIB) and AlgoNomics have joined forces to develop a technology that verifies whether certain proteins induce an immune response in humans. The collaboration between VIB and AlgoNomics has yielded a biological test that supplements the current computer simulations. The additional data enable a more precise determination of the immune response. This knowledge is important for the development of new medicines, because it indicates that a new therapeutic substance is ready to be tested on humans.>>> Discuss This Story
